Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Factorial Study to Evaluate the Efficacy and Safety of Lapaquistat and Simvastatin Alone and in Combination in Subjects With Hypercholesterolemia

NCT00286481 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00286481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00286481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Factorial Study to Evaluate the Efficacy and Safety of Lapaquistat and Simvastatin Alone and in Combination in Subjects With Hypercholesterolemia
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
May 31, 2007
Enrollment
1,362 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia